Andrew R Allen Insider Trading $CLVS Clovis Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Andrew R Allen.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Andrew R Allen. Andrew R Allen is Chief Medical Officer, EVP in PHARMION CORP ($PHRM) and Director in Sierra Oncology, Inc. ($SRRA) and See Remarks in Clovis Oncology, Inc. ($CLVS) and Director in Epizyme, Inc. ($EPZM) and President and CEO in Gritstone Oncology, Inc. ($GRTS) and Director in TCR2 THERAPEUTICS INC. ($TCRR).

Andrew R Allen in Clovis Oncology, Inc.

Trading Symbol: CLVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 04 2015
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Andrew R Allen in Clovis Oncology, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CLVS, EPZM, GRTS, PHRM, SRRA, TCRR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 04 2015CLVSClovis Oncology, I ...Allen Andrew RSee RemarksOption ExerciseA79.0535,0002,766,75035,000

Page:   1